Table of Content

1 CINV Existing and Pipeline Drugs Market Overview
1.1 CINV Existing and Pipeline Drugs Product Scope
1.2 CINV Existing and Pipeline Drugs Segment by Type
1.2.1 Global CINV Existing and Pipeline Drugs Sales by Type (2018 & 2024 & 2034)
1.2.2 Aloxi
1.2.3 Zofran Generic
1.2.4 Kytril Generic
1.2.5 Emend
1.2.6 Akynzeo
1.2.7 SUSTOL
1.2.8 Rolapitant
1.3 CINV Existing and Pipeline Drugs Segment by Application
1.3.1 Global CINV Existing and Pipeline Drugs Sales Comparison by Application (2018 & 2024 & 2034)
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Diagnostic Centers Therapeutics
1.3.5 Hospital Pharmacies
1.3.6 Drugstores
1.4 CINV Existing and Pipeline Drugs Market Estimates and Forecasts (2018-2034)
1.4.1 Global CINV Existing and Pipeline Drugs Market Size in Value Growth Rate (2018-2034)
1.4.2 Global CINV Existing and Pipeline Drugs Market Size in Volume Growth Rate (2018-2034)
1.4.3 Global CINV Existing and Pipeline Drugs Price Trends (2018-2034)
2 CINV Existing and Pipeline Drugs Estimates and Forecasts by Region
2.1 Global CINV Existing and Pipeline Drugs Market Size by Region: 2018 VS 2024 VS 2034
2.2 Global CINV Existing and Pipeline Drugs Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global CINV Existing and Pipeline Drugs Sales Market Share by Region (2018-2023)
2.2.2 Global CINV Existing and Pipeline Drugs Revenue Market Share by Region (2018-2023)
2.3 Global CINV Existing and Pipeline Drugs Market Estimates and Forecasts by Region (2024-2034)
2.3.1 Global CINV Existing and Pipeline Drugs Sales Estimates and Forecasts by Region (2024-2034)
2.3.2 Global CINV Existing and Pipeline Drugs Revenue Forecast by Region (2024-2034)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States CINV Existing and Pipeline Drugs Estimates and Projections (2018-2034)
2.4.2 Europe CINV Existing and Pipeline Drugs Estimates and Projections (2018-2034)
2.4.3 China CINV Existing and Pipeline Drugs Estimates and Projections (2018-2034)
2.4.4 Japan CINV Existing and Pipeline Drugs Estimates and Projections (2018-2034)
2.4.5 Southeast Asia CINV Existing and Pipeline Drugs Estimates and Projections (2018-2034)
2.4.6 India CINV Existing and Pipeline Drugs Estimates and Projections (2018-2034)
3 Global CINV Existing and Pipeline Drugs Competition Landscape by Players
3.1 Global Top CINV Existing and Pipeline Drugs Players by Sales (2018-2023)
3.2 Global Top CINV Existing and Pipeline Drugs Players by Revenue (2018-2023)
3.3 Global CINV Existing and Pipeline Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CINV Existing and Pipeline Drugs as of 2024)
3.4 Global CINV Existing and Pipeline Drugs Average Price by Company (2018-2023)
3.5 Manufacturers CINV Existing and Pipeline Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global CINV Existing and Pipeline Drugs Market Size by Type
4.1 Global CINV Existing and Pipeline Drugs Historic Market Review by Type (2018-2023)
4.1.1 Global CINV Existing and Pipeline Drugs Sales by Type (2018-2023)
4.1.2 Global CINV Existing and Pipeline Drugs Revenue by Type (2018-2023)
4.1.3 Global CINV Existing and Pipeline Drugs Price by Type (2018-2023)
4.2 Global CINV Existing and Pipeline Drugs Market Estimates and Forecasts by Type (2024-2034)
4.2.1 Global CINV Existing and Pipeline Drugs Sales Forecast by Type (2024-2034)
4.2.2 Global CINV Existing and Pipeline Drugs Revenue Forecast by Type (2024-2034)
4.2.3 Global CINV Existing and Pipeline Drugs Price Forecast by Type (2024-2034)
5 Global CINV Existing and Pipeline Drugs Market Size by Application
5.1 Global CINV Existing and Pipeline Drugs Historic Market Review by Application (2018-2023)
5.1.1 Global CINV Existing and Pipeline Drugs Sales by Application (2018-2023)
5.1.2 Global CINV Existing and Pipeline Drugs Revenue by Application (2018-2023)
5.1.3 Global CINV Existing and Pipeline Drugs Price by Application (2018-2023)
5.2 Global CINV Existing and Pipeline Drugs Market Estimates and Forecasts by Application (2024-2034)
5.2.1 Global CINV Existing and Pipeline Drugs Sales Forecast by Application (2024-2034)
5.2.2 Global CINV Existing and Pipeline Drugs Revenue Forecast by Application (2024-2034)
5.2.3 Global CINV Existing and Pipeline Drugs Price Forecast by Application (2024-2034)
6 United States CINV Existing and Pipeline Drugs Market Facts & Figures
6.1 United States CINV Existing and Pipeline Drugs Sales by Company
6.1.1 United States CINV Existing and Pipeline Drugs Sales by Company (2018-2023)
6.1.2 United States CINV Existing and Pipeline Drugs Revenue by Company (2018-2023)
6.2 United States CINV Existing and Pipeline Drugs Sales Breakdown by Type
6.2.1 United States CINV Existing and Pipeline Drugs Sales Breakdown by Type (2018-2023)
6.2.2 United States CINV Existing and Pipeline Drugs Sales Breakdown by Type (2024-2034)
6.3 United States CINV Existing and Pipeline Drugs Sales Breakdown by Application
6.3.1 United States CINV Existing and Pipeline Drugs Sales Breakdown by Application (2018-2023)
6.3.2 United States CINV Existing and Pipeline Drugs Sales Breakdown by Application (2024-2034)
7 Europe CINV Existing and Pipeline Drugs Market Facts & Figures
7.1 Europe CINV Existing and Pipeline Drugs Sales by Company
7.1.1 Europe CINV Existing and Pipeline Drugs Sales by Company (2018-2023)
7.1.2 Europe CINV Existing and Pipeline Drugs Revenue by Company (2018-2023)
7.2 Europe CINV Existing and Pipeline Drugs Sales Breakdown by Type
7.2.1 Europe CINV Existing and Pipeline Drugs Sales Breakdown by Type (2018-2023)
7.2.2 Europe CINV Existing and Pipeline Drugs Sales Breakdown by Type (2024-2034)
7.3 Europe CINV Existing and Pipeline Drugs Sales Breakdown by Application
7.3.1 Europe CINV Existing and Pipeline Drugs Sales Breakdown by Application (2018-2023)
7.3.2 Europe CINV Existing and Pipeline Drugs Sales Breakdown by Application (2024-2034)
8 China CINV Existing and Pipeline Drugs Market Facts & Figures
8.1 China CINV Existing and Pipeline Drugs Sales by Company
8.1.1 China CINV Existing and Pipeline Drugs Sales by Company (2018-2023)
8.1.2 China CINV Existing and Pipeline Drugs Revenue by Company (2018-2023)
8.2 China CINV Existing and Pipeline Drugs Sales Breakdown by Type
8.2.1 China CINV Existing and Pipeline Drugs Sales Breakdown by Type (2018-2023)
8.2.2 China CINV Existing and Pipeline Drugs Sales Breakdown by Type (2024-2034)
8.3 China CINV Existing and Pipeline Drugs Sales Breakdown by Application
8.3.1 China CINV Existing and Pipeline Drugs Sales Breakdown by Application (2018-2023)
8.3.2 China CINV Existing and Pipeline Drugs Sales Breakdown by Application (2024-2034)
9 Japan CINV Existing and Pipeline Drugs Market Facts & Figures
9.1 Japan CINV Existing and Pipeline Drugs Sales by Company
9.1.1 Japan CINV Existing and Pipeline Drugs Sales by Company (2018-2023)
9.1.2 Japan CINV Existing and Pipeline Drugs Revenue by Company (2018-2023)
9.2 Japan CINV Existing and Pipeline Drugs Sales Breakdown by Type
9.2.1 Japan CINV Existing and Pipeline Drugs Sales Breakdown by Type (2018-2023)
9.2.2 Japan CINV Existing and Pipeline Drugs Sales Breakdown by Type (2024-2034)
9.3 Japan CINV Existing and Pipeline Drugs Sales Breakdown by Application
9.3.1 Japan CINV Existing and Pipeline Drugs Sales Breakdown by Application (2018-2023)
9.3.2 Japan CINV Existing and Pipeline Drugs Sales Breakdown by Application (2024-2034)
10 Southeast Asia CINV Existing and Pipeline Drugs Market Facts & Figures
10.1 Southeast Asia CINV Existing and Pipeline Drugs Sales by Company
10.1.1 Southeast Asia CINV Existing and Pipeline Drugs Sales by Company (2018-2023)
10.1.2 Southeast Asia CINV Existing and Pipeline Drugs Revenue by Company (2018-2023)
10.2 Southeast Asia CINV Existing and Pipeline Drugs Sales Breakdown by Type
10.2.1 Southeast Asia CINV Existing and Pipeline Drugs Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia CINV Existing and Pipeline Drugs Sales Breakdown by Type (2024-2034)
10.3 Southeast Asia CINV Existing and Pipeline Drugs Sales Breakdown by Application
10.3.1 Southeast Asia CINV Existing and Pipeline Drugs Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia CINV Existing and Pipeline Drugs Sales Breakdown by Application (2024-2034)
11 India CINV Existing and Pipeline Drugs Market Facts & Figures
11.1 India CINV Existing and Pipeline Drugs Sales by Company
11.1.1 India CINV Existing and Pipeline Drugs Sales by Company (2018-2023)
11.1.2 India CINV Existing and Pipeline Drugs Revenue by Company (2018-2023)
11.2 India CINV Existing and Pipeline Drugs Sales Breakdown by Type
11.2.1 India CINV Existing and Pipeline Drugs Sales Breakdown by Type (2018-2023)
11.2.2 India CINV Existing and Pipeline Drugs Sales Breakdown by Type (2024-2034)
11.3 India CINV Existing and Pipeline Drugs Sales Breakdown by Application
11.3.1 India CINV Existing and Pipeline Drugs Sales Breakdown by Application (2018-2023)
11.3.2 India CINV Existing and Pipeline Drugs Sales Breakdown by Application (2024-2034)
12 Company Profiles and Key Figures in CINV Existing and Pipeline Drugs Business
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Business Overview
12.1.3 GlaxoSmithKline CINV Existing and Pipeline Drugs Sales, Revenue and Gross Margin (2018-2023)
12.1.4 GlaxoSmithKline CINV Existing and Pipeline Drugs Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Helsinn
12.2.1 Helsinn Corporation Information
12.2.2 Helsinn Business Overview
12.2.3 Helsinn CINV Existing and Pipeline Drugs Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Helsinn CINV Existing and Pipeline Drugs Products Offered
12.2.5 Helsinn Recent Development
12.3 Heron Therapeutics
12.3.1 Heron Therapeutics Corporation Information
12.3.2 Heron Therapeutics Business Overview
12.3.3 Heron Therapeutics CINV Existing and Pipeline Drugs Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Heron Therapeutics CINV Existing and Pipeline Drugs Products Offered
12.3.5 Heron Therapeutics Recent Development
12.4 Merck
12.4.1 Merck Corporation Information
12.4.2 Merck Business Overview
12.4.3 Merck CINV Existing and Pipeline Drugs Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Merck CINV Existing and Pipeline Drugs Products Offered
12.4.5 Merck Recent Development
12.5 Tesaro
12.5.1 Tesaro Corporation Information
12.5.2 Tesaro Business Overview
12.5.3 Tesaro CINV Existing and Pipeline Drugs Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Tesaro CINV Existing and Pipeline Drugs Products Offered
12.5.5 Tesaro Recent Development
13 CINV Existing and Pipeline Drugs Manufacturing Cost Analysis
13.1 CINV Existing and Pipeline Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of CINV Existing and Pipeline Drugs
13.4 CINV Existing and Pipeline Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 CINV Existing and Pipeline Drugs Distributors List
14.3 CINV Existing and Pipeline Drugs Customers
15 Market Dynamics
15.1 CINV Existing and Pipeline Drugs Industry Trends
15.2 CINV Existing and Pipeline Drugs Market Drivers
15.3 CINV Existing and Pipeline Drugs Market Challenges
15.4 CINV Existing and Pipeline Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global CINV Existing and Pipeline Drugs Sales (US$ Million) Growth Rate by Type (2018 & 2024 & 2034)
Table 2. Global CINV Existing and Pipeline Drugs Sales ((US$ Million)) Comparison by Application (2018 & 2024 & 2034)
Table 3. Global CINV Existing and Pipeline Drugs Market Size (US$ Million) by Region: 2018 VS 2024 VS 2034
Table 4. Global CINV Existing and Pipeline Drugs Sales (Kg) by Region (2018-2023)
Table 5. Global CINV Existing and Pipeline Drugs Sales Market Share by Region (2018-2023)
Table 6. Global CINV Existing and Pipeline Drugs Revenue (US$ Million) Market Share by Region (2018-2023))
Table 7. Global CINV Existing and Pipeline Drugs Revenue Share by Region (2018-2023)
Table 8. Global CINV Existing and Pipeline Drugs Sales (Kg) Forecast by Region (2024-2034)
Table 9. Global CINV Existing and Pipeline Drugs Sales Market Share Forecast by Region (2024-2034)
Table 10. Global CINV Existing and Pipeline Drugs Revenue (US$ Million) Forecast by Region (2024-2034)
Table 11. Global CINV Existing and Pipeline Drugs Revenue Share Forecast by Region (2024-2034)
Table 12. Global CINV Existing and Pipeline Drugs Sales by Company (Kg) & (2018-2023)
Table 13. Global CINV Existing and Pipeline Drugs Sales Share by Company (2018-2023)
Table 14. Global CINV Existing and Pipeline Drugs Revenue by Company (US$ Million) & (2018-2023)
Table 15. Global CINV Existing and Pipeline Drugs Revenue Share by Company (2018-2023)
Table 16. Global CINV Existing and Pipeline Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CINV Existing and Pipeline Drugs as of 2024)
Table 17. Global Market CINV Existing and Pipeline Drugs Average Price by Company (USD/Kg) & (2018-2023)
Table 18. Manufacturers CINV Existing and Pipeline Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers CINV Existing and Pipeline Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global CINV Existing and Pipeline Drugs Sales by Type (2018-2023) & (Kg)
Table 22. Global CINV Existing and Pipeline Drugs Sales Share by Type (2018-2023)
Table 23. Global CINV Existing and Pipeline Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 24. Global CINV Existing and Pipeline Drugs Price by Type (2018-2023) & (USD/Kg)
Table 25. Global CINV Existing and Pipeline Drugs Sales by Type (2024-2034)
Table 26. Global CINV Existing and Pipeline Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 27. Global CINV Existing and Pipeline Drugs Revenue Share by Type (2024-2034)
Table 28. Global CINV Existing and Pipeline Drugs Price by Type (2024-2034) & (USD/Kg)
Table 29. Global CINV Existing and Pipeline Drugs Sales by Application (2018-2023) & (Kg)
Table 30. Global CINV Existing and Pipeline Drugs Sales Share by Application (2018-2023)
Table 31. Global CINV Existing and Pipeline Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 32. Global CINV Existing and Pipeline Drugs Price by Application (2018-2023) & (USD/Kg)
Table 33. Global CINV Existing and Pipeline Drugs Sales by Application (2024-2034) & (Kg)
Table 34. Global CINV Existing and Pipeline Drugs Sales Share by Application (2024-2034)
Table 35. Global CINV Existing and Pipeline Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global CINV Existing and Pipeline Drugs Revenue Share by Application (2024-2034)
Table 37. Global CINV Existing and Pipeline Drugs Price by Application (2024-2034) & (USD/Kg)
Table 38. United States CINV Existing and Pipeline Drugs Sales by Company (2018-2023) & (Kg)
Table 39. United States CINV Existing and Pipeline Drugs Sales Market Share by Company (2018-2023)
Table 40. United States CINV Existing and Pipeline Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 41. United States CINV Existing and Pipeline Drugs Revenue Market Share by Company (2018-2023)
Table 42. United States CINV Existing and Pipeline Drugs Sales by Type (2018-2023) & (Kg)
Table 43. United States CINV Existing and Pipeline Drugs Sales Market Share by Type (2018-2023)
Table 44. United States CINV Existing and Pipeline Drugs Sales by Type (2024-2034) & (Kg)
Table 45. United States CINV Existing and Pipeline Drugs Sales Market Share by Type (2024-2034)
Table 46. United States CINV Existing and Pipeline Drugs Sales by Application (2018-2023) & (Kg)
Table 47. United States CINV Existing and Pipeline Drugs Sales Market Share by Application (2018-2023)
Table 48. United States CINV Existing and Pipeline Drugs Sales by Application (2024-2034) & (Kg)
Table 49. United States CINV Existing and Pipeline Drugs Sales Market Share by Application (2024-2034)
Table 50. Europe CINV Existing and Pipeline Drugs Sales by Company (2018-2023) & (Kg)
Table 51. Europe CINV Existing and Pipeline Drugs Sales Market Share by Company (2018-2023)
Table 52. Europe CINV Existing and Pipeline Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 53. Europe CINV Existing and Pipeline Drugs Revenue Market Share by Company (2018-2023)
Table 54. Europe CINV Existing and Pipeline Drugs Sales by Type (2018-2023) & (Kg)
Table 55. Europe CINV Existing and Pipeline Drugs Sales Market Share by Type (2018-2023)
Table 56. Europe CINV Existing and Pipeline Drugs Sales by Type (2024-2034) & (Kg)
Table 57. Europe CINV Existing and Pipeline Drugs Sales Market Share by Type (2024-2034)
Table 58. Europe CINV Existing and Pipeline Drugs Sales by Application (2018-2023) & (Kg)
Table 59. Europe CINV Existing and Pipeline Drugs Sales Market Share by Application (2018-2023)
Table 60. Europe CINV Existing and Pipeline Drugs Sales by Application (2024-2034) & (Kg)
Table 61. Europe CINV Existing and Pipeline Drugs Sales Market Share by Application (2024-2034)
Table 62. China CINV Existing and Pipeline Drugs Sales by Company (2018-2023) & (Kg)
Table 63. China CINV Existing and Pipeline Drugs Sales Market Share by Company (2018-2023)
Table 64. China CINV Existing and Pipeline Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 65. China CINV Existing and Pipeline Drugs Revenue Market Share by Company (2018-2023)
Table 66. China CINV Existing and Pipeline Drugs Sales by Type (2018-2023) & (Kg)
Table 67. China CINV Existing and Pipeline Drugs Sales Market Share by Type (2018-2023)
Table 68. China CINV Existing and Pipeline Drugs Sales by Type (2024-2034) & (Kg)
Table 69. China CINV Existing and Pipeline Drugs Sales Market Share by Type (2024-2034)
Table 70. China CINV Existing and Pipeline Drugs Sales by Application (2018-2023) & (Kg)
Table 71. China CINV Existing and Pipeline Drugs Sales Market Share by Application (2018-2023)
Table 72. China CINV Existing and Pipeline Drugs Sales by Application (2024-2034) & (Kg)
Table 73. China CINV Existing and Pipeline Drugs Sales Market Share by Application (2024-2034)
Table 74. Japan CINV Existing and Pipeline Drugs Sales by Company (2018-2023) & (Kg)
Table 75. Japan CINV Existing and Pipeline Drugs Sales Market Share by Company (2018-2023)
Table 76. Japan CINV Existing and Pipeline Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 77. Japan CINV Existing and Pipeline Drugs Revenue Market Share by Company (2018-2023)
Table 78. Japan CINV Existing and Pipeline Drugs Sales by Type (2018-2023) & (Kg)
Table 79. Japan CINV Existing and Pipeline Drugs Sales Market Share by Type (2018-2023)
Table 80. Japan CINV Existing and Pipeline Drugs Sales by Type (2024-2034) & (Kg)
Table 81. Japan CINV Existing and Pipeline Drugs Sales Market Share by Type (2024-2034)
Table 82. Japan CINV Existing and Pipeline Drugs Sales by Application (2018-2023) & (Kg)
Table 83. Japan CINV Existing and Pipeline Drugs Sales Market Share by Application (2018-2023)
Table 84. Japan CINV Existing and Pipeline Drugs Sales by Application (2024-2034) & (Kg)
Table 85. Japan CINV Existing and Pipeline Drugs Sales Market Share by Application (2024-2034)
Table 86. Southeast Asia CINV Existing and Pipeline Drugs Sales by Company (2018-2023) & (Kg)
Table 87. Southeast Asia CINV Existing and Pipeline Drugs Sales Market Share by Company (2018-2023)
Table 88. Southeast Asia CINV Existing and Pipeline Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 89. Southeast Asia CINV Existing and Pipeline Drugs Revenue Market Share by Company (2018-2023)
Table 90. Southeast Asia CINV Existing and Pipeline Drugs Sales by Type (2018-2023) & (Kg)
Table 91. Southeast Asia CINV Existing and Pipeline Drugs Sales Market Share by Type (2018-2023)
Table 92. Southeast Asia CINV Existing and Pipeline Drugs Sales by Type (2024-2034) & (Kg)
Table 93. Southeast Asia CINV Existing and Pipeline Drugs Sales Market Share by Type (2024-2034)
Table 94. Southeast Asia CINV Existing and Pipeline Drugs Sales by Application (2018-2023) & (Kg)
Table 95. Southeast Asia CINV Existing and Pipeline Drugs Sales Market Share by Application (2018-2023)
Table 96. Southeast Asia CINV Existing and Pipeline Drugs Sales by Application (2024-2034) & (Kg)
Table 97. Southeast Asia CINV Existing and Pipeline Drugs Sales Market Share by Application (2024-2034)
Table 98. India CINV Existing and Pipeline Drugs Sales by Company (2018-2023) & (Kg)
Table 99. India CINV Existing and Pipeline Drugs Sales Market Share by Company (2018-2023)
Table 100. India CINV Existing and Pipeline Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 101. India CINV Existing and Pipeline Drugs Revenue Market Share by Company (2018-2023)
Table 102. India CINV Existing and Pipeline Drugs Sales by Type (2018-2023) & (Kg)
Table 103. India CINV Existing and Pipeline Drugs Sales Market Share by Type (2018-2023)
Table 104. India CINV Existing and Pipeline Drugs Sales by Type (2024-2034) & (Kg)
Table 105. India CINV Existing and Pipeline Drugs Sales Market Share by Type (2024-2034)
Table 106. India CINV Existing and Pipeline Drugs Sales by Application (2018-2023) & (Kg)
Table 107. India CINV Existing and Pipeline Drugs Sales Market Share by Application (2018-2023)
Table 108. India CINV Existing and Pipeline Drugs Sales by Application (2024-2034) & (Kg)
Table 109. India CINV Existing and Pipeline Drugs Sales Market Share by Application (2024-2034)
Table 110. GlaxoSmithKline Corporation Information
Table 111. GlaxoSmithKline Description and Business Overview
Table 112. GlaxoSmithKline CINV Existing and Pipeline Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 113. GlaxoSmithKline CINV Existing and Pipeline Drugs Product
Table 114. GlaxoSmithKline Recent Development
Table 115. Helsinn Corporation Information
Table 116. Helsinn Description and Business Overview
Table 117. Helsinn CINV Existing and Pipeline Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 118. Helsinn CINV Existing and Pipeline Drugs Product
Table 119. Helsinn Recent Development
Table 120. Heron Therapeutics Corporation Information
Table 121. Heron Therapeutics Description and Business Overview
Table 122. Heron Therapeutics CINV Existing and Pipeline Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 123. Heron Therapeutics CINV Existing and Pipeline Drugs Product
Table 124. Heron Therapeutics Recent Development
Table 125. Merck Corporation Information
Table 126. Merck Description and Business Overview
Table 127. Merck CINV Existing and Pipeline Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 128. Merck CINV Existing and Pipeline Drugs Product
Table 129. Merck Recent Development
Table 130. Tesaro Corporation Information
Table 131. Tesaro Description and Business Overview
Table 132. Tesaro CINV Existing and Pipeline Drugs Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 133. Tesaro CINV Existing and Pipeline Drugs Product
Table 134. Tesaro Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. CINV Existing and Pipeline Drugs Distributors List
Table 138. CINV Existing and Pipeline Drugs Customers List
Table 139. CINV Existing and Pipeline Drugs Market Trends
Table 140. CINV Existing and Pipeline Drugs Market Drivers
Table 141. CINV Existing and Pipeline Drugs Market Challenges
Table 142. CINV Existing and Pipeline Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. CINV Existing and Pipeline Drugs Product Picture
Figure 2. Global CINV Existing and Pipeline Drugs Sales (US$ Million) by Type (2018 & 2024 & 2034)
Figure 3. Global CINV Existing and Pipeline Drugs Sales Market Share by Type in 2024 & 2034
Figure 4. Aloxi Product Picture
Figure 5. Zofran Generic Product Picture
Figure 6. Kytril Generic Product Picture
Figure 7. Emend Product Picture
Figure 8. Akynzeo Product Picture
Figure 9. SUSTOL Product Picture
Figure 10. Rolapitant Product Picture
Figure 11. Global CINV Existing and Pipeline Drugs Sales (US$ Million) by Application (2018 & 2024 & 2034)
Figure 12. Global CINV Existing and Pipeline Drugs Sales Market Share by Application in 2024 & 2034
Figure 13. Hospitals Examples
Figure 14. Specialty Clinics Examples
Figure 15. Diagnostic Centers Therapeutics Examples
Figure 16. Hospital Pharmacies Examples
Figure 17. Drugstores Examples
Figure 18. Global CINV Existing and Pipeline Drugs Sales, (US$ Million), 2018 VS 2024 VS 2034
Figure 19. Global CINV Existing and Pipeline Drugs Sales Growth Rate (2018-2034) & (US$ Million)
Figure 20. Global CINV Existing and Pipeline Drugs Sales (Kg) Growth Rate (2018-2034)
Figure 21. Global CINV Existing and Pipeline Drugs Price Trends Growth Rate (2018-2034) & (USD/Kg)
Figure 22. Global Market CINV Existing and Pipeline Drugs Market Size (US$ Million) by Region:2018 VS 2024 VS 2034
Figure 23. Global CINV Existing and Pipeline Drugs Revenue Market Share by Region: 2018 VS 2024
Figure 24. United States CINV Existing and Pipeline Drugs Revenue (US$ Million) Growth Rate (2018-2034)
Figure 25. United States CINV Existing and Pipeline Drugs Sales (Kg) Growth Rate (2018-2034)
Figure 26. Europe CINV Existing and Pipeline Drugs Revenue (US$ Million) Growth Rate (2018-2034)
Figure 27. Europe CINV Existing and Pipeline Drugs Sales (US$ Million) Growth Rate (2018-2034)
Figure 28. China CINV Existing and Pipeline Drugs Revenue (US$ Million) Growth Rate (2018-2034)
Figure 29. China CINV Existing and Pipeline Drugs Sales (US$ Million) and Growth Rate (2018-2034)
Figure 30. Japan CINV Existing and Pipeline Drugs Revenue (US$ Million) Growth Rate (2018-2034)
Figure 31. Japan CINV Existing and Pipeline Drugs Sales (US$ Million) Growth Rate (2018-2034)
Figure 32. Southeast Asia CINV Existing and Pipeline Drugs Revenue (US$ Million) Growth Rate (2018-2034)
Figure 33. Southeast Asia CINV Existing and Pipeline Drugs Sales (US$ Million) Growth Rate (2018-2034)
Figure 34. India CINV Existing and Pipeline Drugs Revenue (US$ Million) Growth Rate (2018-2034)
Figure 35. India CINV Existing and Pipeline Drugs Sales (US$ Million) Growth Rate (2018-2034)
Figure 36. Global 5 Largest CINV Existing and Pipeline Drugs Players Market Share by Revenue in CINV Existing and Pipeline Drugs: 2018 & 2024
Figure 37. CINV Existing and Pipeline Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 38. Global CINV Existing and Pipeline Drugs Revenue Share by Type (2018-2023)
Figure 39. Global CINV Existing and Pipeline Drugs Sales Share by Type (2024-2034)
Figure 40. Global CINV Existing and Pipeline Drugs Revenue Share by Type (2024-2034)
Figure 41. Global CINV Existing and Pipeline Drugs Revenue Share by Application (2018-2023)
Figure 42. Global CINV Existing and Pipeline Drugs Revenue Growth Rate by Application in 2018 & 2024
Figure 43. Global CINV Existing and Pipeline Drugs Sales Share by Application (2024-2034)
Figure 44. Global CINV Existing and Pipeline Drugs Revenue Share by Application (2024-2034)
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of CINV Existing and Pipeline Drugs
Figure 47. Manufacturing Process Analysis of CINV Existing and Pipeline Drugs
Figure 48. CINV Existing and Pipeline Drugs Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed